ReviewCurrent issues in molecular biology2024

Regulatory Assessment of Casgevy for the Treatment of Transfusion-Dependent β-Thalassemia and Sickle Cell Disease with Recurrent Vaso-Occlusive Crises.

Essam Kerwash et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.